Drugs for autoimmune diseases like lupus that block only one of the two principal signaling pathways can activate an overabundance of one potentially disease-causing type of immune cell population over another, a Yale study has found.
http://ift.tt/1mcxqYU
http://ift.tt/1mcxqYU
No comments:
Post a Comment